Profound Medical Corp. (PROF) Tops Q4 EPS by 57c

Profound Medical Corp. (NASDAQ: PROF) reported Q4 EPS of $0.27, $0.57 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $6 million versus the consensus estimate of $7.9 million.

For earnings history and earnings-related data on Profound Medical Corp. (PROF) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BTIG Starts Take-Two Interactive (TTWO) at Buy
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook